Cargando…
Weekly Iron Folate Supplementation in Adolescent Girls – An Effective Nutritional Measure for the Management of Iron Deficiency Anaemia
INTRODUCTION: Nutritional anaemia in India is common morbidity seen in late adolescent and young female population. There are many conflicting opinions regarding dosage of iron folic acid supplementation for managing this simple nutritional deficiency disorder. Hence, this ‘Randomized Controlled Tri...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Canadian Center of Science and Education
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776831/ https://www.ncbi.nlm.nih.gov/pubmed/23618489 http://dx.doi.org/10.5539/gjhs.v5n3p188 |
Sumario: | INTRODUCTION: Nutritional anaemia in India is common morbidity seen in late adolescent and young female population. There are many conflicting opinions regarding dosage of iron folic acid supplementation for managing this simple nutritional deficiency disorder. Hence, this ‘Randomized Controlled Trial’ was undertaken in adolescent girls suffering from Iron Deficiency Anaemia visiting ‘Urban Health and Training Centre’ situated in urban slum area. The aim of this study was to assess the (a) Impact of weekly iron folic acid supplementation in comparison with daily iron supplementation for the management of Iron Deficiency Anaemia in adolescent girls visiting ‘Urban Health and Training Centre’; (b) Adverse drug reaction profile in ‘Weekly Iron Folic Acid Supplementation’ and ‘Daily Iron Folic Acid Supplementation’ regimes; (c) Compliance profile for ‘Weekly Iron Folic Acid Supplementation’ and ‘Daily Iron Folic Acid Supplementation’ regimes in adolescent girls. METHODS AND MATERIAL: Randomized controlled trial was conducted in adolescent girls visiting ‘Urban Health and Training Centre’ during the study period June, 2011 to October, 2012. The 120 anaemic (Haemoglobin < 12 gm%) adolescent girls (10-19 years) were distributed randomly by block randomization in two groups; one receiving daily Iron and Folic Acid supplementation and in other group receiving weekly Iron and Folic Acid supplementation for 3 months. All the study subjects were given de-worming (Albendazole 400 mg) and required health education separately. Both the groups were monitored for Haemoglobin estimation, compliance and adverse drug reactions, if any. Open-Epi Statistical Software was used for data analysis. RESULTS: The mean age of study subjects in ‘Daily Iron and Folic Acid Supplementation’ and ‘Weekly Iron and Folic Acid Supplementation’ group was 13.48 and 13.55 years respectively. Their mean pre intervention Haemoglobin was 10.1±1.1 gm/dl and 10.4±1.1 gm/dl respectively. The mean rise in Haemoglobin after lean period of 1 month in respective groups was almost equal i.e. 1.0±0.7 gm/dl and 1.0±0.8 gm/dl. Adverse Drug Reactions were 8.3% in weekly regime as compared to 13.35% in daily regime, abdominal pain being the commonest adverse drug reaction seen. The compliance calculated as mean of unconsumed ‘Iron and Folic Acid’ tablets was 6.1±10.98 in ‘Daily Iron Folic Acid Supplementation’ group, while it was 1.3±3.15 in ‘Weekly Iron Folic Acid Supplementation’ group (p=0.0012), making weekly regime more promising than daily regime with better treatment compliance. CONCLUSIONS: Weekly supplementation of ‘Iron and Folic Acid’ in ‘Iron Deficiency Anaemia’ patients is as good as daily supplementation with added benefits of less adverse reactions and better compliance. |
---|